登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：600682证券简称：南京新百公告编号：临2025-026 南京新街口百货商店股份有限公司 第十届董事会第二十次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 南京新街口百货商店股份有限公司（以下简称公司）第十届董事会第二十次会议（以下简称会议）于 2025年9月22日以通讯表决的方式召开。会议通知于2025年9月19日以邮件的方式向全体董事发出，本次 会议应参会董事11人，实际参会董事11人。本次会议的通知、召开以及参与表决董事人数均符合有关法 律、法规、规则及《公司章程》的规定，会议审议并通过了如下议案： 一、审议通过了公司《关于注销回购股份并减少注册资本的议案》 详见上海证券交易所网站（www.sse.com.cn）披露的《南京新百关于注销回购股份并减少注册资本的公 告》。 本议案尚需提交至公司股东大会审议。 表决结果：同意11票，反对0票，弃权0票。 二、审议通过了公司《关于召开2025年第一次临时股东大会的议案》 详见上海证券交易所网站（www ...

Core Viewpoint - Tianqi Lithium Industries, Inc. has announced a change in the purpose of part of its repurchased shares, shifting from an incentive plan to cancellation and reduction of registered capital [2][3]. Group 1: Share Repurchase and Capital Reduction - The company held meetings on August 29 and September 22, 2025, where it approved the change in the purpose of repurchased shares from "used for A-share restricted stock incentive plan" to "used for cancellation and reduction of registered capital" [2]. - The total share capital will decrease from 1,641,221,583 shares to 1,641,194,983 shares, and the registered capital will correspondingly reduce from 1,641,221,583 RMB to 1,641,194,983 RMB [3]. Group 2: Creditor Notification - The company has notified creditors that they have 45 days from the announcement date to claim debts or request guarantees, ensuring that the validity of their claims remains unaffected if not exercised within the timeframe [3]. Group 3: Shareholder Meeting Details - The second extraordinary general meeting of shareholders was held on September 22, 2025, with a total of 2,238 participants representing 540,652,703 shares, accounting for 32.9690% of the total voting shares [14]. - The proposal to change the purpose of repurchased shares was approved by more than two-thirds of the voting rights held by shareholders present at the meeting [15].

Core Viewpoint - The company has approved a change in the purpose of repurchased shares, shifting from an equity incentive plan to cancellation and reduction of registered capital [1] Summary by Sections Company Actions - The company will hold its ninth board meeting on August 27, 2025, and the third extraordinary shareholders' meeting on September 15, 2025 [1] - The company has agreed to change the use of 63,900 repurchased shares from "for equity incentive plan" to "for cancellation and corresponding reduction of registered capital" [1] Financial Impact - Following this change, the total share capital will remain at 1.555 billion shares, and the registered capital will also remain at 1.555 billion yuan [1] Creditors' Rights - Creditors can apply to the company for claims starting from September 16, 2025, for a period of 45 days [1]

证券代码：002432 证券简称：九安医疗 公告编号：2025-062 天津九安医疗电子股份有限公司 本公司及监事会全体成员保证信息披露的内容真实、准确和完整， 没有虚假记载、误导性陈述或重大遗漏。 天津九安医疗电子股份有限公司(以下简称"公司"或"本公司")于2025年9月2 日以书面方式发出召开第六届监事会第二十次会议的通知，会议于2025年9月5 日在公司会议室以现场表决方式召开。本次会议由公司监事会主席姚凯先生主持， 会议应参加的监事3名，实际参加的监事3名，会议的召集、召开与表决程序符合 《公司法》等法律法规及《公司章程》的规定。与会监事就会议议案进行了审议 及表决，通过了如下议案： 此议案尚需提交股东大会审议通过后方可实施。 特此公告。 天津九安医疗电子股份有限公司监事会 一、以3票同意、0票反对、0票弃权的表决结果，审议通过了《关于变更部 分回购股份用途并注销的议案》 经审议，监事会认为本次变更部分回购股份用途符合《上市公司股份回购规 《深圳证券交易所上市公司自律监管指引第 9 号——回购股份》等相关规定， 则》 不存在损害公司及全体股东利益的情形，不会对公司财务、经营、研发、债务履 行能力等产 ...

Core Viewpoint - The company plans to adjust the purpose of repurchased shares from employee stock ownership plans to cancellation, aiming to enhance shareholder value and maintain investor confidence [1][5]. Summary by Sections 1. Basic Information on Share Repurchase - The company approved a share repurchase plan on January 10, 2024, with a total repurchase amount between RMB 300 million and RMB 500 million, at a maximum price of RMB 58 per share, within a 12-month period [1][2]. 2. Adjustment of Share Repurchase Purpose - The company intends to adjust the use of 6,000,000 shares from the repurchase account, changing it from "for employee stock ownership plans" to "for cancellation" [1][3]. 3. Changes in Total Depository Receipts - After the cancellation of 6,000,000 shares, the total number of depository receipts will decrease from 719,444,662 to 713,444,662 [4]. 4. Reasons and Impacts of the Adjustment - The decision is based on the company's operational situation and strategic planning, aiming to enhance returns for depository receipt holders without negatively impacting the company's financial status or debt obligations [5]. 5. Decision-Making Process - The adjustment has been approved by the company's board and will be submitted for shareholder approval, ensuring compliance with relevant laws and regulations [5].

Core Viewpoint - The company plans to change the purpose of repurchased shares from "for employee stock ownership plan" to "cancel and reduce registered capital" for 615,667 shares, which represents 0.23% of the total share capital [1][2][4]. Summary by Sections Share Repurchase Implementation - The company approved a share repurchase plan on December 31, 2020, with a total fund of no less than RMB 120 million and no more than RMB 160 million, to be completed within 12 months [2]. - The repurchase price was capped at RMB 72.00 per share, with a total transaction amount of RMB 12 million [2]. Change of Purpose and Cancellation - The board of directors agreed to change the purpose of the repurchased shares from "for employee stock ownership plan" to "cancel and reduce registered capital" due to the failure to unlock shares in the first employee stock ownership plan [3][4]. - After the cancellation, the total share capital will decrease from 266,451,202 shares to 265,835,535 shares, and registered capital will reduce from RMB 266,451,202 to RMB 265,835,535 [1][4]. Impact of the Change - The change in the purpose of repurchased shares and cancellation is expected to have no significant impact on the company's financial status or operational results, nor will it affect the company's debt repayment ability or ongoing operations [5][6]. - The company maintains that this decision does not harm the interests of shareholders, especially minority shareholders, and will not lead to changes in the controlling shareholder or actual controller [6]. Decision-Making Process - The decision was made during the 22nd meeting of the third board of directors and the 19th meeting of the third supervisory board on July 23, 2025, and requires approval from the shareholders' meeting [6][7]. - The supervisory board supports the decision, confirming that it complies with relevant regulations and does not harm the interests of the company or its shareholders [7].

Core Viewpoint - The company is holding its second extraordinary general meeting of shareholders in 2025 to discuss important matters including share repurchase, cancellation of the supervisory board, and the appointment of the auditing firm for the fiscal year 2025 [2][7][11]. Group 1: Shareholder Meeting Procedures - The meeting aims to maintain the legal rights of all shareholders and ensure orderly proceedings [2]. - Only authorized personnel, including shareholders, directors, supervisors, and invited guests, are allowed to attend the meeting [3]. - Late attendees can participate in discussions but cannot vote if they arrive after voting has commenced [3][4]. - Shareholders have the right to speak, inquire, and vote during the meeting, with specific procedures for raising questions and making statements [5][6]. Group 2: Share Repurchase and Capital Reduction - The company approved a share repurchase plan in May 2022, allocating between RMB 50 million and RMB 100 million for repurchasing shares at a maximum price of RMB 69 per share [7][15]. - As of August 16, 2022, the company repurchased a total of 960,396 shares, representing a certain percentage of the total share capital [7][15]. - The company plans to cancel these repurchased shares, reducing the total share capital from 206,490,816 shares to 205,530,420 shares, and the registered capital from RMB 20,649,081.6 to RMB 20,553,042.0 [10][15]. Group 3: Governance Changes - The company proposes to abolish the supervisory board, transferring its responsibilities to the audit committee of the board of directors, in line with new regulations effective from July 1, 2024 [11][12]. - The company will revise its articles of association and related governance documents to reflect these changes [14][17]. - The proposed changes aim to enhance corporate governance and protect the interests of investors, particularly minority shareholders [17]. Group 4: Auditing Firm Appointment - The company recommends reappointing Tianheng Accounting Firm for the 2025 fiscal year, maintaining the audit fee at RMB 1.16 million, consistent with the previous year [12][13]. - The firm has demonstrated the necessary qualifications and experience in providing auditing services to listed companies [12]. Group 5: Other Proposals - The company will revise its internal regulations to improve operational standards and governance structures [17]. - The revisions will be comprehensive, addressing various aspects of corporate governance in accordance with relevant laws and regulations [17].

Buyback Approval and Plan - The board of directors approved a share buyback plan using self-owned funds through centralized bidding on January 23, 2024, with a total fund amount between 200 million yuan and 400 million yuan, and a maximum buyback price of 7 yuan per share [1] Buyback Implementation - The company initiated its first share buyback on January 29, 2024, and completed the buyback by July 21, 2024, acquiring 63.579048 million shares, which is 2.47% of the total share capital at that time. The highest buyback price was 5.00 yuan per share, the lowest was 4.08 yuan, and the average price was 4.72 yuan, with a total expenditure of approximately 299.9241 million yuan [2][3] Use of Funds and Impact - The funds used for the buyback were from the company's own resources and did not significantly impact its daily operations, financial status, or future development. The buyback did not alter the company's control or affect its listing status [3] Shareholder Trading Activity - During the buyback period, company directors, supervisors, and senior management did not trade company shares, except for the controlling shareholder, Zhejiang Pharmaceutical Health Industry Group, which planned to increase its stake by 2% to 4% of the total share capital [3] Change in Buyback Share Purpose - The purpose of the repurchased shares was changed from "for equity incentives" to "for cancellation to reduce registered capital" as approved in board meetings held on April 23 and May 2025 [3] Cancellation of Repurchased Shares - The company announced a notification to creditors regarding the cancellation of repurchased shares, with a creditor declaration period from May 24 to July 7, 2025. No creditors requested early debt repayment or guarantees during this period [5] Post-Cancellation Share Capital Changes - After the cancellation of shares, the total share capital will decrease from 2,585,167,996 shares to 2,521,588,948 shares, reflecting a change in ownership percentages among shareholders [6] Shareholder Ownership Changes - Following the cancellation, the controlling shareholder, Zhejiang Pharmaceutical Health Industry Group, maintained its shareholding at 594,209,740 shares, increasing its ownership percentage from 22.99% to 23.56% [6]

证券代码：603259 证券简称：药明康德 公告编号：临 2025-041 公司已于 2025 年 4 月 9 日在上海证券交易所网站（www.sse.com.cn）及指定 媒体披露《关于回购注销部分股票通知债权人的公告》（公告编号：临 2025-026）， 至今公示期已满 45 天。公示期间未接到债权人申报债权并要求公司清偿债务或者 提供相应担保的情况。 公司曾于 2025 年 3 月 18 日披露《关于 2025 年以集中竞价交易方式回购 A 股 股份的预案》（公告编号：2025-017），且该预案项下的回购方案（以下简称"2025 年第一次回购股份方案"）已于 2025 年 4 月 29 日经公司召开的 2024 年年度股东 大会审议通过。本次回购股份方案不影响 2025 年第一次回购股份方案的独立实施。 二、 回购实施情况 披露了首次回购股份情况，具体内容详见公司于上海证券交易所网站 （www.sse.com.cn）及指定媒体披露的《关于 2025 年第二次以集中竞价交易方式 首次回购公司股份暨股份回购进展公告》（公告编号：临 2025-030）。 易方式回购 A 股股份 15,775,377 股，占 ...

Group 1 - The company plans to change the purpose of the repurchased shares from "selling through centralized bidding" to "cancellation and reduction of registered capital" [1][2] - A total of 5,007,526 shares, which is 0.53% of the company's total share capital, will be canceled and the registered capital will decrease from 946,275,005 yuan to 941,267,479 yuan [2] - The board of directors requests authorization from the shareholders' meeting for the management to handle the cancellation and related procedures [2] Group 2 - The repurchase of shares was conducted from June 1, 2022, to May 30, 2025, with 5,000,000 shares sold during this period, representing 0.53% of the total share capital [1] - The change in the purpose of the repurchased shares is aligned with the company's operational situation and development strategy, aimed at enhancing shareholder value and investor confidence [1][2] - The cancellation of the shares will not significantly impact the company's financial status, operational results, or shareholder equity, nor will it affect the company's listing status [2]